MedPath

G&E HERBAL BIOTECHNOLOGY CO., LTD

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:6

Trial Phases

3 Phases

Phase 1:2
Phase 2:4
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (57.1%)
Phase 1
2 (28.6%)
Phase 3
1 (14.3%)

Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

Phase 1
Completed
Conditions
Actinic Keratosis
Interventions
Drug: SR-T100 Gel
First Posted Date
2015-09-25
Last Posted Date
2019-07-15
Lead Sponsor
G&E Herbal Biotechnology Co., LTD
Target Recruit Count
12
Registration Number
NCT02559934
Locations
🇨🇳

National Cheng Kung University Hospital, Tainan, Taiwan

Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis

Phase 2
Completed
Conditions
Actinic Keratosis
Bowen's Disease
Interventions
Drug: SR-T100 ® Gel
First Posted Date
2014-03-12
Last Posted Date
2014-03-14
Lead Sponsor
G&E Herbal Biotechnology Co., LTD
Target Recruit Count
27
Registration Number
NCT02085395
Locations
🇨🇳

National Cheng Kung University Hospital, Tainan, Taiwan

Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

Phase 1
Completed
Conditions
Actinic Keratosis
Interventions
Drug: SR-T100 gel
First Posted Date
2014-01-07
Last Posted Date
2015-08-13
Lead Sponsor
G&E Herbal Biotechnology Co., LTD
Target Recruit Count
2
Registration Number
NCT02029066
Locations
🇨🇳

National Cheng Kung University Hospital, Tainan, Taiwan

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

Phase 2
Suspended
Conditions
Common Wart
Interventions
Drug: Vehicle gel
Drug: SR-T100 gel with 1.0% of SM
Drug: SR-T100 gel with 2.3% of SM
First Posted Date
2013-02-22
Last Posted Date
2023-09-14
Lead Sponsor
G&E Herbal Biotechnology Co., LTD
Target Recruit Count
102
Registration Number
NCT01796795

Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

Phase 2
Completed
Conditions
Genital Warts
Venereal Warts
Condylomata Acuminata
Condyloma Acuminata
Interventions
Drug: SR-T100 gel with 1.0 % SM
Drug: Vehicle gel
Drug: SR-T100 gel with 2.3% SM
First Posted Date
2013-02-22
Last Posted Date
2020-02-05
Lead Sponsor
G&E Herbal Biotechnology Co., LTD
Target Recruit Count
138
Registration Number
NCT01796821
Locations
🇨🇳

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

🇨🇳

Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

🇨🇳

National Cheng Kung University Hospital, Tainan, Taiwan

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.